tradingkey.logo
tradingkey.logo
Search

Veraxa Biotech AG Ord Shs

VRXA
Add to Watchlist
1.760USD
-0.200-10.20%
Close 07-31 16:00ETQuotes delayed by 15 min
248.88MMarket Cap
--P/E TTM

VRXA Financials

See Veraxa Biotech AG Ord Shs's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Veraxa Biotech AG Ord Shs Earnings Date

Latest Release
Jun 16, 2026
EPS / Forecast
--/--
Revenue / Forecast
--/--
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
0.28
--
Analyst Rating
--
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
Financial Indicators
EPS
--0.01
Net Profit
--180.50K
Operating profit
---2.19M
Net Profit
--180.50K
Current assets
--44.33K
Total current liabilities
--274.68M
Total assets
--272.28M
Total liabilities
--286.73M
Total equity
---14.45M
Net operating income
---149.31K
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.